Chemical modifications on SARS-CoV-2 RNA
RNA epigenetic modifications in SARS-CoV-2
Researchers are looking at whether tiny chemical tags on the coronavirus's RNA change how the virus copies itself and how our immune system reacts, which could help people affected by COVID-19.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11269226 on NIH RePORTER |
What this research studies
This work maps two common chemical RNA tags (m6A and pseudouridine) on SARS‑CoV‑2 using high‑resolution sequencing from human bronchial airway cells. The team will reduce or alter the host enzymes that add these tags to see how that changes virus replication and viral gene activity. They will also study how these RNA modifications affect innate and adaptive immune responses in human cell models. The goal is to understand the mechanisms so new antiviral strategies or vaccine improvements might be developed.
Who could benefit from this research
Good fit: People who recently had or currently have COVID‑19, or recovered individuals willing to donate airway samples or nasal/bronchial cells, would be most relevant for contributing samples to this work.
Not a fit: People without exposure to SARS‑CoV‑2 or those looking for immediate clinical treatment are unlikely to benefit directly from this basic laboratory research.
Why it matters
Potential benefit: If successful, the project could reveal new targets or strategies for antiviral drugs or vaccine designs that better control SARS‑CoV‑2.
How similar studies have performed: Laboratory studies of other viruses and early work on SARS‑CoV‑2 suggest RNA modifications can change viral replication, but translating those findings into therapies is still new.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Li, Jianrong — Ohio State University
- Study coordinator: Li, Jianrong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.